#glp-1
6 articles with this tag
HealthMass. GLP-1 Gamble: Equity Implications of Price Control
Unpacking Massachusetts' bold GLP-1 price control plan. Discover the surprising equity implications & whether rationing innovation truly delivers savings.
HealthWegovy & Mounjaro: NHS Costs Signal Access Stakes
Uncover the complex economics behind Wegovy & Mounjaro. Our analysis reveals how NHS costs expose critical access challenges & reshape healthcare's future.
HealthOzempic & Wegovy: Bone & Gout Risks Signal Long-Term Stakes
Uncover the hidden risks of Ozempic & Wegovy! Our analysis reveals emerging bone & gout concerns, challenging the weight loss hype & demanding a deeper look.
BusinessOzempic & Wegovy Price Cuts: A Strategic Shift Analyzed
Uncover the *real* reason behind Novo Nordisk’s Ozempic & Wegovy price cuts. Our analysis reveals a strategic shift reshaping GLP-1 access—beyond the headlines.
BusinessOzempic's Impact: How Puris Proteins Built a $200M Empire
Uncover the surprising link between Ozempic & pea protein! See how Puris Proteins built a $200M empire by anticipating the 'Ozempic generation's' needs.
HealthGLP-1 Crackdown: Makary & the Future of Drug Access
Uncover the hidden forces behind the GLP-1 drug debate! Our analysis reveals how FDA oversight, market demand, & Dr. Makary's actions reshape access.